Clinical presentation by ATLL subtype
| Patient characteristics . | Acute (n = 13) . | Lymphomatous (n = 13) . | Chronic/smoldering (n = 4) . |
|---|---|---|---|
| Age, y | 63 | 59 | 58 |
| WBC, 109/ L | 23.1 | 6.4 | 12.25 |
| Corrected calcium, mg/dl | 13.88 | 11.52 | 9.88 |
| Albumin, g/dl | 3.6 | 3.5 | 3.9 |
| Lactate dehydrogenase, U/L | 676 | 561 | 280 |
| TP53 mutation, % (n) | |||
| Mutated | 38 (5) | 15 (2) | 0 (0) |
| Unmutated | 62 (8) | 85 (11) | 100 (4) |
| Any epigenetic mutation, % (n) | |||
| Mutated | 54 (7) | 54 (7) | 75 (3) |
| Unmutated | 46 (6) | 46 (6) | 25 (1) |
| Patient characteristics . | Acute (n = 13) . | Lymphomatous (n = 13) . | Chronic/smoldering (n = 4) . |
|---|---|---|---|
| Age, y | 63 | 59 | 58 |
| WBC, 109/ L | 23.1 | 6.4 | 12.25 |
| Corrected calcium, mg/dl | 13.88 | 11.52 | 9.88 |
| Albumin, g/dl | 3.6 | 3.5 | 3.9 |
| Lactate dehydrogenase, U/L | 676 | 561 | 280 |
| TP53 mutation, % (n) | |||
| Mutated | 38 (5) | 15 (2) | 0 (0) |
| Unmutated | 62 (8) | 85 (11) | 100 (4) |
| Any epigenetic mutation, % (n) | |||
| Mutated | 54 (7) | 54 (7) | 75 (3) |
| Unmutated | 46 (6) | 46 (6) | 25 (1) |